Comparison of the cost-effectiveness of milnacipran (a SNRI) with TCAs and SSRIs: a modeling approach. [electronic resource]
Producer: 20000502Description: 152-62 p. digitalISSN:- 0924-9338
- Adrenergic Antagonists -- economics
- Adult
- Antidepressive Agents, Tricyclic -- economics
- Cost-Benefit Analysis
- Cyclopropanes -- economics
- Depressive Disorder, Major -- drug therapy
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Tolerance -- physiology
- Female
- Follow-Up Studies
- Humans
- Male
- Milnacipran
- Models, Econometric
- Sensitivity and Specificity
- Selective Serotonin Reuptake Inhibitors -- economics
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.